C-Cayr Pharmaceuticals Private Limited
About C-Cayr Pharmaceuticals Private Limited
Data last updated:
C-Cayr Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 13 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2018PTC125629.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Maheswari Panuganti and Suresh Vemula.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H No 4 – 3 – 187/28 Seetharampuram Anmagal Hayathnagar, Hyderabad, Telangana, India – 501505.
As per the financials filed for FY 2024, the company reported a revenue of ₹34,456, a decline of 83% compared to the previous year. For the same year it recorded a net loss of ₹4,180 (net margin -12.1%) and EBITDA of -₹4,180 (EBITDA margin -12.1%). Revenue has declined at a compounded annual rate (CAGR) of 40% over three years and 22% over five years.
Company details
Contact details
C-Cayr Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH No 4 – 3 – 187/28 Seetharampuram Anmagal Hayathnagar, Hyderabad, Telangana, India – 501505
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of C-Cayr Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of C-Cayr Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of C-Cayr Pharmaceuticals Private Limited, buy the company report.
Financials of C-Cayr Pharmaceuticals Private Limited
FY 2024 filings availableC-Cayr Pharmaceuticals Private Limited reported revenue of ₹34,456 (down 83% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 83% fall in the latest year. EBITDA fell 144% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4,180 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4,180 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.1% | ||||
| Net Profit Margin | -12.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of C-Cayr Pharmaceuticals Private Limited, buy the company report.
Board of directors of C-Cayr Pharmaceuticals Private Limited
C-Cayr Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maheswari Panuganti Also directs: Exlr Pharmaceuticals Private Limited | Director | 13 Jul 2018 | 8 Years 3 Months | Current |
| Suresh Vemula Also directs: Growero Technologies Private Limited | Director | 08 Aug 2022 | 4 Years 2 Months | Current |
Peer comparison
C-Cayr Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Uniglen Pharmaceuticals (OPC) Private Limited | ₹35,181 (FY 2024) | Hyderabad, Telangana, India | ||||
| Aarna Pharmaceuticals Private Limited | ₹34,780 (FY 2025) | -64.0% | Gorakhpur, Uttar Pradesh, India | |||
| C-Cayr Pharmaceuticals Private Limitedthis company | ₹34,456 (FY 2024) | -₹4,180 | -12.1% | -83.0% | Hyderabad, Telangana, India | |
| Sayone Pharmaceuticals Private Limited | ₹33,945 (FY 2022) | 3068.0% | New Delhi, Delhi, India |
To see the full peer comparison of C-Cayr Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving C-Cayr Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for C-Cayr Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for C-Cayr Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
C-Cayr Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Suresh Vemula was appointed as Director on 08 Aug 2022.
Frequently asked questions
C-Cayr Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 13 July 2018 (8+ years old) and is registered under CIN U24304TG2018PTC125629.
C-Cayr Pharmaceuticals has 2 current directors:
- Maheswari Panuganti - Director
- Suresh Vemula - Director
The latest financial statements of C-Cayr Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of C-Cayr Pharmaceuticals is U24304TG2018PTC125629. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
C-Cayr Pharmaceuticals was incorporated on 13 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of C-Cayr Pharmaceuticals by revenue are Uniglen Pharmaceuticals (OPC) Private Limited, Aarna Pharmaceuticals Private Limited, Sayone Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Suresh Vemula was appointed as Director on 08 Aug 2022. Venkataravikanth Panuganti ceased to be Director on 08 Aug 2022. Maheswari Panuganti was appointed as Director on 13 Jul 2018.
The registered office of C-Cayr Pharmaceuticals is at H No 4 – 3 – 18728 Seetharampuram Anmagal Hayathnagar, Hyderabad, Telangana, India – 501505.
C-Cayr Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
C-Cayr Pharmaceuticals can be reached at its registered office: H No 4 – 3 – 18728 Seetharampuram Anmagal Hayathnagar, Hyderabad, Telangana, India – 501505.
C-Cayr Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
